What is Kodiak Sciences Inc's change in AP?

Kodiak Sciences Inc (KOD) reported change in AP of -$733K in Q1 2026.

How has Kodiak Sciences Inc's change in AP changed year-over-year?

Kodiak Sciences Inc's change in AP decreased by 128.1% year-over-year, from $2.61M to -$733K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Kodiak Sciences Inc KOD Change in AP

Change in AP at other companies

Regeneron PharmaceuticalsREGN

$107.7M+150%

HRO

HarrowHROW

$3.38M+130%

Viridian Therapeutics, Inc.VRDN

$4.63M+162%

Ocular TherapeutixOCUL

$3.72M+53,029%

Vera TherapeuticsVERA

-$7.97M-599%

Arcutis Biotherapeutics, Inc.ARQT

$5.61M+1,717%

Other financials

Income statement

See full

Operating income-$59.8M-1.2%

Net income-$58.2M-1.2%

EPS (diluted)-$0.94+13.8%

Balance sheet

See full

Cash & equivalents$169.5M+22.1%

Total debt$56.0M-17.2%

Total equity$112.1M+3.0%

Total assets$306.0M+2.7%

Cash flow

See full

Operating cash flow-$40.0M-37.6%

CapEx$942.0K+249%

Free cash flow-$41.0M-39.5%

Valuation

See full

Market cap$2.32B+1,477%

Enterprise value$2.2B+2,798%

Returns & leverage

See full

Return on equity-208.8%+2,306pp

Debt / equity0.5×-0.1×

Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kodiak Sciences Inc's change in AP?: Kodiak Sciences Inc (KOD) reported change in AP of -$733K in Q1 2026.
How has Kodiak Sciences Inc's change in AP changed year-over-year?: Kodiak Sciences Inc's change in AP decreased by 128.1% year-over-year, from $2.61M to -$733K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.